← Back to Search

Behavioural Intervention

Lymfit for Cancer Survivors (Lymfit Trial)

N/A

Waitlist Available

Research Sponsored by McGill University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 months

Awards & highlights

Lymfit Trial Summary

This trial is testing a physical activity intervention for young adult lymphoma survivors to see if it is feasible and acceptable. The goal is to see if the intervention can promote exercise motivation among young adult lymphoma survivors.

Eligible Conditions

Lymphoma
Cancer Survivors

Lymfit Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Acceptability of the study procedures assessed using a set of self-report items

Retention rate from baseline to end of intervention

Secondary outcome measures

Change from baseline Exercise level assessed by the Godin-Shephard leisure-time physical activity questionnaire (LTPA-Q)

Change from baseline Exercise motivation assessed by the Behavioral Regulation in Exercise Questionnaire (BREQ-3)

Change from baseline Psychological Need Satisfaction assessed by The Psychological Need Satisfaction in Exercise (PNSE) scale

+1 more

Lymfit Trial Design

2Treatment groups

Experimental Treatment

Group I: Wait-list control armExperimental Treatment1 Intervention

The control group participants will begin receiving the Lymfit intervention 3 months after they sign the consent form.

Group II: Lymfit interventionExperimental Treatment1 Intervention

Participants randomized to the intervention group will be allocated a pre-registered Inspire II model Fitbit. The kinesiologist will design a personalized exercise prescription for the participant. The kinesiologist will follow up with the participants every 2 weeks for 3 months to discuss their progress and to modify or advance their exercise prescriptions as needed.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Lymfit Intervention

2022

N/A

~30

Wait-list control

2020

Completed Phase 3

~1230

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

McGill UniversityLead Sponsor

394 Previous Clinical Trials

998,355 Total Patients Enrolled

3 Trials studying Lymphoma

105 Patients Enrolled for Lymphoma

Jewish General HospitalOTHER

137 Previous Clinical Trials

272,018 Total Patients Enrolled

1 Trials studying Lymphoma

50 Patients Enrolled for Lymphoma

McGill University Health Centre/Research Institute of the McGill University Health CentreOTHER

442 Previous Clinical Trials

159,148 Total Patients Enrolled

2 Trials studying Lymphoma

90 Patients Enrolled for Lymphoma

Media Library

LymFit (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05259657 — N/A

Lymphoma Research Study Groups: Lymfit intervention, Wait-list control arm

Lymphoma Clinical Trial 2023: LymFit Highlights & Side Effects. Trial Name: NCT05259657 — N/A

LymFit (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05259657 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals are actively participating in this experiment?

"Affirmative. Clinicaltrials.gov indicates that this research endeavor was first posted on February 1, 2022 and is now actively recruiting participants with the goal of enrolling 28 patients from a single location."

Answered by AI

Is this experiment currently recruiting participants?

"According to records on clinicaltrials.gov, this research initiative is actively enrolling participants and has been since February 1st 2022, with the latest amendment occuring on May 20th of that same year."

Answered by AI

What objectives is this research seeking to fulfill?

"This clinical trial will measure the efficacy of its intervention by assessing a participant's retention rate over three months. Secondary outcomes include changes in psychological need satisfaction, exercise levels, and quality of life as evaluated through The Psychological Need Satisfaction in Exercise (PNSE) scale, Godin-Shephard leisure-time physical activity questionnaire (LTPA-Q), and Patient-Reported Outcomes Measurement Information System (PROMIS-Preference)."

Answered by AI

Are senior citizens included in the enrollment criteria for this trial?

"This research initiative demands that participants are between 18 and 39, however there are 308 clinical trials for minors and 1,593 studies geared towards geriatric patients."

Answered by AI

What type of participant is most ideal for this research study?

"To meet the eligibility criteria for this trial, interested individuals must have lymphoma and be within 18 to 39 years of age. There is a total available enrollment of 28 participants."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Feasibility, Acceptability, and Preliminary Effects of Lymfit

Christine Maheu 2022. "Feasibility, Acceptability, and Preliminary Effects of Lymfit". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05259657.